Jonathan S Zager

52PUBLICATIONS
104CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jan 14, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial.

Andrew S Brohl, Vernon K Sondak, Evan J Wuthrick

|Jan 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Juan Alban, R Christopher Bowen, David A Reichstein

|Dec 08, 2025
ASO Visual Abstract: Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative or Not Performed Sentinel Lymph Node Biopsy.

Michelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin

|Nov 08, 2025
ASO Author Reflections: Merkel Cell Carcinoma and Nodal Staging with SLNB.

Michelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin

|Oct 31, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy.

Michelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin

|Aug 21, 2025
Response to Letter to the Editor Regarding: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

Jonathan S Zager, Johnny John

Pageof 9

Frequent Collaborators

5 joint publications

Michael J Carr

5 joint publications

Vernon K Sondak

4 joint publications

Ahmad Tarhini

4 joint publications

Danielle K DePalo